Skip to content
Global Institute for Novel Nicotine
Global Institute for Novel NicotineGlobal Institute for Novel Nicotine
  • Home
  • Science & Regulations
    • Science
    • Standards
    • Regulations
    • Fighting Illicit Trade
  • News
  • GINN Regions
    • GINN MENA
      • GINN’s Strategic Partnership with ClinLia
    • GINN EU
      • GINN Lithuania
      • GINN Spain
  • About
    • About GINN
    • Members
    • The Team
    • GINN Media Partners
    • Focal Points
    • What is Nicotine?
    • Core Principles
    • Contact Us
  • Events
    • GINN Get Together
    • GINN@EVONXT
    • GINN Inaugural Panel
    • InterTabac 2025
      • Navigating EU’s TPD3
      • Oral Nicotine Innovation
  • 📢 COP11 Announcement
Search:
Linkedin page opens in new windowInstagram page opens in new windowYouTube page opens in new window
  • Home
  • Science & Regulations
    • Science
    • Standards
    • Regulations
    • Fighting Illicit Trade
  • News
  • GINN Regions
    • GINN MENA
      • GINN’s Strategic Partnership with ClinLia
    • GINN EU
      • GINN Lithuania
      • GINN Spain
  • About
    • About GINN
    • Members
    • The Team
    • GINN Media Partners
    • Focal Points
    • What is Nicotine?
    • Core Principles
    • Contact Us
  • Events
    • GINN Get Together
    • GINN@EVONXT
    • GINN Inaugural Panel
    • InterTabac 2025
      • Navigating EU’s TPD3
      • Oral Nicotine Innovation
  • 📢 COP11 Announcement

Daily Archives: January 17, 2025

You are here:
  1. Home
  2. 2025
  3. January
  4. 17

FDA Issues PMTA for Nicotine Pouches: A Clear Regulatory Pathway Emerges

NewsBy GINNJanuary 17, 2025Leave a comment

The U.S. Food and Drug Administration (FDA) has taken a landmark step in tobacco harm reduction by authorizing the marketing of 20 ZYN nicotine pouch products. This authorization, granted under the Premarket Tobacco Product Application (PMTA) process, establishes a clear regulatory pathway for nicotine pouches, reinforcing their role as a viable alternative for adult smokers…

© 2025 All rights reserved | Global Institute for Novel Nicotine

Go to Top